Wilms' tumor gene WT1: its oncogenic function and clinical application.
about
Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patientsThe Wilms' Tumor Gene WT1 - 17AA/- KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer ModelSingle nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinomaCancer immunotherapy targeting Wilms' tumor gene WT1 product.A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells.Cancer Immunotherapy for Gliomas: Overview and Future DirectionsSyndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine.Therapies currently in Phase II trials for malignant pleural mesothelioma.Peptide vaccines for hematological malignancies: a missed promise?Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.Tumor Vaccines for Malignant Gliomas.WT1 silencing by RNAi synergizes with chemotherapeutic agents and induces chemosensitization to doxorubicin and cisplatin in B16F10 murine melanoma cells.Wilms' tumor protein Wt1 regulates the Interleukin-10 (IL-10) gene.Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein.Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues.Changes in expression of WT1 during induced differentiation of the acute myeloid leukemia cell lines by treatment with 5-aza-2'-deoxycytidine and all-trans retinoic acid.Expression of Wilms tumor gene in high risk neuroblastoma: complementary marker to tyrosine hydroxylase for detection of minimal residual disease.Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia.WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases.Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood.Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients.Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients: an important role of bone marrow as a secondary lymphoid organ.Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies.Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences.WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups.Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.Co-inhibition of TIGIT, PD1, and Tim3 reverses dysfunction of Wilms tumor protein-1 (WT1)-specific CD8+ T lymphocytes after dendritic cell vaccination in gastric cancer
P2860
Q28975750-00602A41-A99C-454E-A133-CD518E9DB393Q34478581-2C19C19F-A96F-44FE-B028-FA5C9D2444B1Q34618828-4579E4B4-9562-4658-BAAD-4E53CCF2E9A3Q36238704-24435F1C-FED6-42FC-9384-A5CBD7C9C686Q36943923-E24417E1-86E0-4DF3-A161-4C4894EB3E73Q37095891-BA7D474D-2CA2-41C3-A1F5-672317BDDE2FQ37591458-4A89244F-5783-4055-A3F5-0DFF881552D1Q38118385-DD79E64E-5EB9-43A6-9C48-EC9CE97C45AAQ38176546-D91867DD-5C6A-4A30-B182-7AAA63ABF45FQ38362636-8F655C99-93FF-41D0-A8EE-ECBAE4601309Q39228039-139267E5-7BDE-4998-A069-6FCD5D14C6C8Q39323696-CF35419F-DD65-4ADB-A70C-D50E53A63B0EQ39640174-05D9BEED-3026-43D3-9D3A-DCFE0F6BCAB2Q40228775-E9B0C1F3-3F6D-41AF-82CF-7F25CACF5F5AQ40484689-D3BC34AD-C1A1-4A39-B16B-589790B6E62EQ42538957-C284E361-1D57-42CF-9FA8-D1E40A0D7FD3Q43066010-13EE3240-A3EB-4C20-9396-64CA6A9F013CQ44586307-344AADA0-4EFE-4A37-BDC8-3823202BE2FEQ44805701-5EC1B52E-7A63-4003-AD35-FD87FE101F29Q50279411-4935F9A6-74C9-48DC-B0FE-2AC1D7EA94D4Q50743741-F2620172-54BA-44C8-AC58-F2DED98C45E3Q50971977-72FA0340-FE45-4948-A79D-772B8CADA613Q51887293-2C20F9E0-E9A6-4565-AFF2-F727557872A1Q52969773-3D85FCA8-BECF-4292-9FC0-7AF4FBB01208Q54318403-949849E2-0A1C-477B-9763-E50E20BD936FQ54331723-73076D1B-4493-4176-B888-3001E3F580FEQ54627391-4E957003-8854-49D9-8D79-0FBA09E1DBBAQ58804593-A2552EE3-938B-43C8-9122-0AE002D81FB5
P2860
Wilms' tumor gene WT1: its oncogenic function and clinical application.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@ast
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@en
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@nl
type
label
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@ast
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@en
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@nl
prefLabel
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@ast
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@en
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@nl
P356
P1476
Wilms' tumor gene WT1: its oncogenic function and clinical application.
@en
P2093
Sugiyama H
P2888
P304
P356
10.1007/BF02981935
P577
2001-02-01T00:00:00Z
P6179
1041602981